Overt Obscure Gastrointestinal Bleeding
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Overt Obscure Gastrointestinal Bleeding trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Overt Obscure Gastrointestinal Bleeding trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Gastrointestinal bleeding originating from the small bowel is difficult to diagnose and treat because the small bowel is difficult to see and reach. Balloon ass…
Up to 5% of patients with recurrent gastrointestinal (GI) bleeding remain undiagnosed by upper endoscopy and colonoscopy, the presumed source of bleeding in the…
Up to 5% of patients with recurrent gastrointestinal (GI) bleeding remain undiagnosed by EGD and colonoscopy, the presumed source of bleeding in these patients…
Overt obscure gastrointestinal bleeding (OGIB) is a distinct clinical entity with significantly worse outcomes compared with colonic bleeding and upper GI bleed…
This study compares wireless capsule endoscopy (patients swallow a pill-size camera that sends pictures of the intestine to a recorder worn on their belt) to an…
To compare the diagnostic yield of mesenteric angiogram with CE in patients with active obscure GIB.